Instill Science

A place to discuss science, share work, and find mentors and collaborators

Instill Science / post-3L8fcSAW
January 13, 2023jan-zheng

The Antibacterial Resistance Leadership Group will begin a phase 1b/2, multicenter, randomized, double-blind, placebo-controlled trial to examine safety and microbiological activity of phage therapy in persons with cystic fibrosis colonized with Pseudomonas aeruginosa.
Phage Therapy Clinical trial Cystic fibrosis
Loading ...
No comments yet. Be the first to comment!